Vertex Pharmaceuticals (VRTX) Capital Expenditures Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 227.76% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.57% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 143.40% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 227.76% |
| Dec 31, 2025 | 61.34% |
| Sep 30, 2025 | 50.37% |
| Jun 30, 2025 | 111.16% |
| Mar 31, 2025 | -40.50% |
| Dec 31, 2024 | 59.38% |
| Sep 30, 2024 | 66.75% |
| Jun 30, 2024 | 15.77% |
| Mar 31, 2024 | 62.47% |
| Dec 31, 2023 | 72.92% |
| Sep 30, 2023 | -25.09% |
| Jun 30, 2023 | 11.82% |
| Mar 31, 2023 | -33.81% |
| Dec 31, 2022 | -45.63% |
| Sep 30, 2022 | 3.44% |
| Jun 30, 2022 | 6.81% |
| Mar 31, 2022 | -10.30% |
| Dec 31, 2021 | 29.58% |
| Sep 30, 2021 | -70.02% |
| Jun 30, 2021 | 179.33% |
| Mar 31, 2021 | 264.52% |
| Dec 31, 2020 | 185.40% |
| Sep 30, 2020 | 619.59% |
| Jun 30, 2020 | 9.21% |
| Mar 31, 2020 | 7.81% |
| Dec 31, 2019 | 6.80% |
| Sep 30, 2019 | 16.16% |
| Jun 30, 2019 | -44.76% |
| Mar 31, 2019 | -38.38% |
| Dec 31, 2018 | -63.60% |
| Sep 30, 2018 | -25.21% |
| Jun 30, 2018 | 70.40% |
| Mar 31, 2018 | 163.80% |
| Dec 31, 2017 | 190.67% |
| Sep 30, 2017 | 101.40% |
| Jun 30, 2017 | 9.17% |
| Mar 31, 2017 | -7.31% |
| Dec 31, 2016 | 18.05% |
| Sep 30, 2016 | 57.82% |
| Jun 30, 2016 | 18.61% |
| Mar 31, 2016 | 13.41% |
| Dec 31, 2015 | -14.64% |
| Sep 30, 2015 | -5.39% |
| Jun 30, 2015 | 14.69% |
| Mar 31, 2015 | -32.00% |
| Dec 31, 2014 | 1.42% |
| Sep 30, 2014 | -49.78% |
| Jun 30, 2014 | 549.69% |
| Mar 31, 2014 | -6.51% |
| Dec 31, 2013 | -48.40% |
| Sep 30, 2013 | -13.47% |
| Jun 30, 2013 | -88.41% |
| Mar 31, 2013 | 169.81% |
| Dec 31, 2012 | 200.63% |
| Sep 30, 2012 | 114.28% |
| Mar 31, 2012 | 26.91% |
| Dec 31, 2011 | -35.34% |
| Sep 30, 2011 | -7.80% |
| Mar 31, 2011 | 55.95% |
| Dec 31, 2010 | 90.39% |
| Sep 30, 2010 | 127.86% |
| Jun 30, 2010 | 111.21% |
| Mar 31, 2010 | -52.73% |